Güllü Topal Görgün

Güllü Topal Görgün

AstraZeneca, Sweden - Södertälje / Sweden
Medical and Health Sciences / Hematology
AD Scientific Index ID: 4399956
-
person_outline Güllü Topal Görgün's MOST POPULAR ARTICLES
1-) Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug The Journal of clinical investigation 118 (7), 2427-2437, 2008
2-) Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans Blood, The Journal of the American Society of Hematology 121 (15), 2975-2987, 2013
3-) Targeting the bone marrow microenvironment in multiple myeloma Immunological reviews 263 (1), 160-172, 2015
4-) Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells The Journal of clinical investigation 115 (7), 1797-1805, 2005
5-) Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cellsG Görgün, TAW Holderried, D Zahrieh, D Neuberg, JG GribbenThe Journal of clinical investigation 115 (7), 1797-1805, 20053772005